Both in Lab Analytical Instruments
Cytek Biosciences vs 10x Genomics
Over the past year CTKB returned +54.1% and TXG returned +384.7%; their daily moves had a correlation of 0.40.
CTKB +54.1% TXG +384.7%Growth of $1, one year, split-adjusted
| Metric | CTKB | TXG |
|---|---|---|
| Price | $6.07 | $66.41 |
| Market cap | $789.0M | $8.65B |
| Today | +1.85% | +1.71% |
| 1 month | +12.8% | −17.7% |
| 6 months | +22.9% | +192.0% |
| Year to date | +20.2% | +307.1% |
| 1 year | +54.1% | +384.7% |
| Revenue growth (YoY) | +5.6% | −12.6% |
| Gross margin | 58.9% | 74.5% |
| Net margin | −25.3% | −11.9% |
| P/E (TTM) | — | — |
| Price / sales | 3.8× | 14.0× |
| Net cash | $261.8M | $552.0M |
| Dividend yield | — | — |
| Volatility (60d) | 50.4% | 85.8% |
| Short % of float | 3.8% | 10.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).